"Renal Dialysis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION.
| Descriptor ID |
D006435
|
| MeSH Number(s) |
E02.870.300 E02.912.800
|
| Concept/Terms |
Renal Dialysis- Renal Dialysis
- Dialyses, Renal
- Renal Dialyses
- Dialysis, Renal
|
Below are MeSH descriptors whose meaning is more general than "Renal Dialysis".
Below are MeSH descriptors whose meaning is more specific than "Renal Dialysis".
This graph shows the total number of publications written about "Renal Dialysis" by people in this website by year, and whether "Renal Dialysis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 1 | 2 |
| 1996 | 2 | 1 | 3 |
| 1997 | 2 | 0 | 2 |
| 1998 | 5 | 0 | 5 |
| 1999 | 4 | 1 | 5 |
| 2000 | 3 | 2 | 5 |
| 2001 | 4 | 1 | 5 |
| 2002 | 3 | 0 | 3 |
| 2003 | 5 | 1 | 6 |
| 2004 | 4 | 2 | 6 |
| 2005 | 4 | 3 | 7 |
| 2006 | 5 | 2 | 7 |
| 2007 | 6 | 4 | 10 |
| 2008 | 11 | 2 | 13 |
| 2009 | 5 | 2 | 7 |
| 2010 | 2 | 6 | 8 |
| 2011 | 2 | 4 | 6 |
| 2012 | 2 | 1 | 3 |
| 2013 | 8 | 2 | 10 |
| 2014 | 2 | 5 | 7 |
| 2015 | 9 | 2 | 11 |
| 2016 | 3 | 3 | 6 |
| 2017 | 11 | 1 | 12 |
| 2018 | 10 | 6 | 16 |
| 2019 | 7 | 1 | 8 |
| 2020 | 5 | 7 | 12 |
| 2021 | 3 | 11 | 14 |
| 2022 | 0 | 5 | 5 |
| 2023 | 0 | 7 | 7 |
| 2024 | 5 | 4 | 9 |
To return to the timeline,
click here.
Below are the most recent publications written about "Renal Dialysis" by people in Profiles.
-
Reliability and benefit of estimated continuous cardiac output measurement using shunt-side SpO2 monitor in hemodialysis. Ther Apher Dial. 2025 Feb; 29(1):61-69.
-
Effectiveness of tenapanor for treating hyperphosphatemia in patients receiving dialysis: a plain language summary of the OPTIMIZE study. Curr Med Res Opin. 2024 Aug; 40(8):1335-1343.
-
Tenapanor: A Phosphate Absorption Inhibitor for the Management of Hyperphosphatemia in Patients With Kidney Failure. J Ren Nutr. 2025 Jan; 35(1):25-34.
-
CCL14 Predicts Oliguria and Dialysis Requirement in Patients with Moderate to Severe Acute Kidney Injury. Blood Purif. 2024; 53(7):548-556.
-
Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study. Kidney360. 2024 May 01; 5(5):732-742.
-
Major Adverse Kidney Events in Pediatric Continuous Kidney Replacement Therapy. JAMA Netw Open. 2024 02 05; 7(2):e240243.
-
Impact of Obesity on Kidney Transplant Outcomes in Older Adults. Transplant Proc. 2024 Jan-Feb; 56(1):58-67.
-
Time to Continuous Renal Replacement Therapy Initiation and 90-Day Major Adverse Kidney Events in Children and Young Adults. JAMA Netw Open. 2024 01 02; 7(1):e2349871.
-
The Detrimental Impact of End-Stage Kidney Disease Is Not Reflected in Autopsy Reports. Arch Pathol Lab Med. 2024 Jan 01; 148(1):74-77.
-
Serum Phosphorus Management with Sucroferric Oxyhydroxide as a First-Line Phosphate Binder within the First Year of Hemodialysis. Am J Nephrol. 2024; 55(2):127-135.